CASC2 and hepatocellular carcinoma: CASC2 expression is down-regulated in the primary tumor, and more down-regulated in advanced stages; higher CASC2 expression causes slight up-regulation in the survival of patients with hepatocellular carcinoma, while lower miR-24 and miR-221 expression is correlated with longer survival of patients with hepatocellular carcinoma.